Clinical Trials for Hutchmed

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hutchmed

Clinical Trials (9)

NCT07025018
Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations
PHASE1Recruiting
52 participants
Started: Jul 15, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06584032
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
PHASE3Recruiting
412 participants
Started: Dec 12, 2024 · Completed: Jun 9, 2029
1 condition1 sponsor17 locations
NCT06601504
Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
PHASE2Active, not recruiting
61 participants
Started: Nov 5, 2024 · Completed: Nov 12, 2026
1 condition1 sponsor16 locations
NCT06387082
A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
PHASE1Recruiting
132 participants
Started: May 27, 2024 · Completed: Dec 8, 2027
1 condition1 sponsor16 locations
NCT06361888
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
PHASE2/PHASE3Recruiting
552 participants
Started: May 8, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor2 locations
NCT06387069
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
PHASE3Recruiting
316 participants
Started: Apr 26, 2024 · Completed: Sep 30, 2029
1 condition1 sponsor53 locations
NCT05886374
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
PHASE1Recruiting
81 participants
Started: Jul 6, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05522231
Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)
PHASE2/PHASE3Active, not recruiting
265 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor48 locations
NCT04353375
Phase 2 Study of HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
PHASE2Recruiting
128 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location